Skip to main content
. 2012 Feb 15;2012(2):CD008280. doi: 10.1002/14651858.CD008280.pub2
Study Reason for exclusion
Baroody 2001 ALLOCATION
Randomised controlled trial
PARTICIPANTS
Patients with perennial allergic rhinitis (not atrophic rhinitis)
Borgstein 1993 ALLOCATION
Not a true RCT, compared groups were not totally similar and the study had insufficient information available
Fang 1998 ALLOCATION 
 Clinical controlled trial (not a RCT)
Jaswal 2008 ALLOCATION
Randomised controlled trial
PARTICIPANTS
30 patients with primary atrophic rhinitis
INTERVENTIONS 
 Oral rifampicin plus nasal wash versus nasal submucosal placentrex injection plus nasal wash and a control group (nasal wash)
OUTCOMES
Excluded on the basis of insufficient duration of follow‐up. Oral rifampicin showed most promising results regarding objective, subjective and histopathological improvement with maximum disease‐free interval on regular follow‐up as compared to submucosal placentrex injections, while both performed better than control group.
Johnsen 2001 ALLOCATION 
 Randomised cross‐over study
PARTICIPANTS
Non‐specific nasal dryness (not atrophic rhinitis)
Kehrl 1998 ALLOCATION
Randomised, double‐blind study
PARTICIPANTS 
 Rhinitis sicca anterior (not atrophic rhinitis)
Klemi 1980 ALLOCATION: 
 Non‐randomised double‐blind study (patients with allergic rhinitis)
Klossek 2001 ALLOCATION
Not randomised
Laliberte 2000 ALLOCATION
Not randomised
Mehrotra 2005 ALLOCATION
Not randomised
Nemeth 2002 ALLOCATION
Not randomised
Nielsen 1995 ALLOCATION: 
 Case series revealing clinical response in 10 patients with ozaena
Schwartz 2007 ALLOCATION
Not randomised
Shehata 1996 ALLOCATION 
 A review article with no treatment arm
Stoll 1958 ALLOCATION 
 Possibly a case series of a single agent (inplacen) response in a series of patients. The study is very old, in the German language and incomplete information information is available to conclude exclusion
Stoor 1999 ALLOCATION
Not randomised

RCT: randomised controlled trial